DABIGATRAN ETEXILATE CAPSULES
Alembic gets USFDA nod for generic medicationAlembic Pharmaceuticals announced approval from the USFDA to market Dabigatran Etexilate Capsules (110 mg) for deep vein thrombosis prophyl...
Alembic Pharma gets USFDA nod for Dabigatran Etexilate capsulesAlembic Pharmaceuticals Ltd received final approval from the US health regulator for generic Dabigatran Etexilate capsules 75 mg and 150 mg...
Market falls for 3rd day in a row; Sensex down 575 pts; Nifty drops below 17,650The back-to-back selloff came as investors digested the implications of a hawkish Federal Reserve and awaited the outcome of RBI's monetary...
Alembic Pharma gets tentative USFDA nod for generic version of Dabigatran Etexilate capsulesThe tentatively approved ANDA is therapeutically equivalent to the reference listed drug (RLD) product Pradaxa Capsules, 75 mg, 110 mg, and...
Load More